Net Loss Per Share Attributable to Common Stockholders (Tables)

6 Months Ended

Jun. 30, 2022

Summary of Net Loss Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts):


	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Numerator:
Net loss attributable to common stockholders (1)	$	(11,718)	$	(5,335)	$	(40,476)	$	(13,192)
Denominator:
Weighted-average common shares used in computed net loss per share attributable to common stockholders basic and diluted	110,812,198		22,531,185		110,599,437		22,383,324
Net loss per share attributable to common stockholders basic and diluted	$	(0.11)	$	(0.24)	$	(0.37)	$	(0.59)

(1) For the three and six months ended June 30, 2021, the Company did not allocate its net loss to participating redeemable convertible preferred stock as those shares are not obligated to share in the losses of the Company. As of June 30, 2022, the Company no longer has participating redeemable convertible preferred stock.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share due to their anti-dilutive effect:


			As of June 30,
			2022
Stock options			9,311,638
RSUs			6,761,820
PRSUs			1,842,105
ESPP shares committed			249,889
Common stock warrants			18,100,000
Total			36,265,452

The Company’s 2,807,500 unvested earnout shares were excluded from the calculation of basic and diluted per share calculations as the vesting conditions have not yet been met as of June 30, 2022.


			As of June 30,
			2021
Stock options			10,903,309
Common stock warrants			942,623
Convertible notes			4,626,183
Preferred stock			61,809,312
Preferred stock warrants			889,765
Total (1)			79,171,192

(1) Securities shown as of June 30, 2021 have been retrospectively adjusted reflecting the exchange ratio of approximately 2.053 established in the Merger. See Part II, Item 8 "Financial Statements and Supplementary Data - Note 3 to the Consolidated Financial Statements - Merger" in the 2021 Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "Form 10-K") for more information.